Integration of Pharmaceutical Discovery and Development
Case Histories
In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- mace…
Mehr
CHF 330.50
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Freidinger, Roger M. (Hrsg.) / Sawyer, Tomi K. (Hrsg.) / Smith, Philip L. (Hrsg.)
- ISBN: 978-0-306-47384-5
- EAN: 9780306473845
- Produktnummer: 37289591
- Verlag: Springer US
- Sprache: Englisch
- Erscheinungsjahr: 2006
- Seitenangabe: 610 S.
- Plattform: PDF
- Auflage: 1998
- Reihenbandnummer: 11
5 weitere Werke von Ronald T. (Hrsg.) Borchardt:
Bewertungen
Anmelden